FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCogstate Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
CGS.AX
Cogstate Limited Stock AnalysisComprehensive stock analysis for Cogstate Limited (CGS.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCGS.AX
CGS.AX
Cogstate Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
CGS.AX
  1. Home
  2. Stocks
  3. Cogstate Limited

Cogstate Limited

🇦🇺CGS.AX•ASX

Cogstate Limited

🇦🇺CGS.AX•ASX
P/E ratio
35.15

Your view on CGS.AX

P/E
35.15
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cogstate Limited

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Bradley John O'Connor
Headquarters
161 Collins Street, Melbourne, VIC, AU
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Bradley John O'Connor
Headquarters
161 Collins Street, Melbourne, VIC, AU
Description

Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations.

Its comprehensive suite of cognitive services includes project and data management, scientific consulting, statistical analysis, procurement of assessment scales, rater training, and monitoring solutions. The company operates through two distinct divisions.

The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases, pharmaceuticals, medical devices, or other interventions on human participants in clinical studies, primarily serving pharmaceutical and biotechnology clients.

Concurrently, its Healthcare segment offers Cognigram, a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline. By June 30, 2022, Cogstate had participated in an estimated 1,800 academic research initiatives.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Cogstate Limited from FRC's valuation model, read against the market price. CGS.AX last traded at AUD 2.59, 35.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cogstate Limited. Starting points for Cogstate Limited: P/E 35.1, EPS AUD 0.07, beta 0.20 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Cogstate Limited. Cogstate Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cogstate Limited. Trailing twelve-month EPS for Cogstate Limited stands at AUD 0.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimate$0.05$0.07$0.13$0.17
Lowest estimate$0.05$0.07$0.13$0.15
Highest estimate$0.05$0.07$0.14$0.20
Number of analysts1133
A year ago$0.04$0.06$0.07—
Growth vs a year ago+43.8%+32.1%+92.0%—

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimate$50.93M$61.88M$113.41M$130.42M
Lowest estimate$50.93M$61.88M$111.17M$125.85M
Highest estimate$50.93M$61.88M$116.81M$134.59M
Number of analysts1144
A year ago$23.94M$30.01M$59.87M—
Growth vs a year ago+112.7%+106.2%+89.4%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cogstate Limited. Cogstate Limited has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CGS.AX16 companies · 2 funds
Compare CGS.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
HIQ.AXHITIQ LimitedHealthcareMedical - Healthcare Information Services—
PCK.AXPainChek LimitedHealthcareMedical - Healthcare Information Services—
PKY.AXPathkey.AI LtdHealthcareMedical - Healthcare Information Services—
TD1.AXTALi Digital LimitedHealthcareMedical - Healthcare Information Services—
TRI.AXTrivarX LimitedHealthcareMedical - Healthcare Information Services—
More Medical - Healthcare Information Services companies
TickerTypeCompanySectorExchangeMkt cap
TEMTempus AI, Inc.HealthcareNASDAQ$11.3B
TSTTFTripSitter Clinic Ltd.HealthcareOTC$145,814
TXG10x Genomics, Inc.HealthcareNASDAQ$6.9B
UDOC.CNUnidoc Health Corp.HealthcareCNQ$12.5M
UDOCFUnidoc Health Corp.HealthcareOTC$7.6M
UMCNUMC, Inc.HealthcareOTC$13.2M
UPHLUpHealth, Inc.HealthcareOTC$5,679
USPSUltimate Sports, Inc.HealthcareOTC$679,298
VASOVaso CorporationHealthcareOTC$31.7M
VFX.AXVisionflex Fpo [vfx]HealthcareASX—
VHI.TOVitalhub Corp.HealthcareTSX$421.8M
ETFs holding Cogstate Limited
TickerFundFund assets% of the fund
AVDSAvantis International Small Cap Equity ETF$379M in assets0.01%
DFSIDimensional - International Sustainability Core 1 ETF$1.2B in assets0.00%

Largest holders first, then the funds most concentrated in CGS.AX.

Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cogstate Limited.

CGS.AX AnalysisGood
Past
4
Growth
5
Health
5
Profit
4
Value
1